{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors", "item": "https://www.patentleaderboard.com/patent/7329495"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors

Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors

US Patent 7329495 · Granted Feb 12, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Macrolide derivatives, preparation method and application thereof2025
Mutants of respiratory syncytial virus fusion proteins2025
Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use ther2025
Pyrimidine derivative, method for preparing same and use thereof in medicine2025
Engineered Hansenula fungi efficiently expressing CA10 virus-like particles and 2025
Piperazine amide derivative, preparation method therefor, and use thereof in med2025
Specific DNA fragment of female Acipenser Dabryanus and method for identifying t2024
Prefusion RSV F proteins and their use2024
Indazole amine derivative, preparation method therefor and medical use thereof2024
Pyrimidine derivative, method for preparing same and use thereof in medicine2023
Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use ther2023
Fused tricyclic heterocycle compounds and therapeutic uses thereof2022